If you have ever read a certificate of analysis and wondered how are peptides made at the chemical level, the answer for nearly every research peptide on the market is a technique called solid-phase peptide synthesis, or SPPS. Rather than coaxing a living cell to express a sequence, chemists build the peptide one amino acid at a time on a tiny insoluble bead. This article walks through the chemistry of that process so you can understand what actually happens before a compound reaches a research vial.
The core idea: how are peptides made on a solid support
SPPS was introduced by Bruce Merrifield in the early 1960s and is widely described as a paradigm shift for synthetic chemistry, because it made the assembly of defined sequences practical and, eventually, automatable. The central innovation is anchoring the growing peptide chain to a solid polymer support (a resin bead) while every reagent flows past in solution. Because the peptide stays physically attached to the bead, excess reagents and byproducts can simply be washed away by filtration between each step. This “attach, react, wash, repeat” cycle is what allows a chain of dozens of residues to be assembled with far fewer purification bottlenecks than classical solution-phase chemistry.
Peptides are directional molecules with an amino (N) terminus and a carboxyl (C) terminus. SPPS is built C-to-N: the first amino acid is tethered through its C-terminus to the resin, and each new residue is added to the exposed N-terminal amine. Managing that directionality and preventing unwanted side reactions is the entire engineering challenge, and it is solved with protecting groups.
Protecting groups and the Fmoc strategy
Every amino acid has reactive side chains as well as its backbone amine and acid. To make coupling selective, chemists mask these groups. Modern SPPS overwhelmingly uses the Fmoc/tBu strategy, in which the temporary N-terminal protecting group (Fmoc, 9-fluorenylmethoxycarbonyl) is removed with a mild base at each cycle, while the more durable side-chain protecting groups stay in place until the very end. A review of Fmoc SPPS notes that it is now the method of choice, supported by high-quality, low-cost building blocks produced at industrial scale for therapeutic peptide manufacturing.
Two protecting groups that come off under different conditions are described as orthogonal. This orthogonality is what makes controlled, stepwise assembly possible, and more elaborate multi-dimensional protecting-group schemes have been developed to build branched and macrocyclic peptides where specific residues must be unmasked selectively during synthesis.
The synthesis cycle, step by step
A single elongation cycle in Fmoc SPPS repeats the same sequence of operations for each residue:
- Deprotection: the Fmoc group on the terminal amine is removed with a base (commonly piperidine), exposing a free amine ready to react.
- Washing: solvent flushes away the spent reagents and the released Fmoc byproduct.
- Coupling: the next Fmoc-protected amino acid is activated by a coupling reagent and forms a new amide (peptide) bond to the free amine. Coupling reagent systems such as carbodiimides with additives like Oxyma are used to drive this step efficiently while limiting racemization.
- Washing again: excess amino acid and activator are rinsed away before the cycle repeats.
Because each cycle is only ever as good as its efficiency, small losses compound across a long sequence, so optimizing coupling and deprotection is central to producing clean material. Difficult sequences that aggregate on the resin are a recurring practical challenge that the field continues to address.
Resins, linkers, and cleavage
The resin is not just an inert bead. It is joined to the peptide through a chemical linker (sometimes called a handle) whose properties determine how and when the finished chain is released. Linker chemistry also sets whether the product ends up as a free acid or an amide at the C-terminus, and specialized “safety-catch” linkers stay completely stable during assembly and are only activated to release the peptide by a deliberate chemical trigger at the end. Reviews of Fmoc handles catalogue linkers designed to release either fully deprotected peptides or protected fragments for later assembly.
Once the full sequence is built, a cleavage step (typically a strong acid such as trifluoroacetic acid in Fmoc/tBu chemistry) simultaneously detaches the peptide from the resin and removes the side-chain protecting groups. The crude peptide is then precipitated, purified (usually by reverse-phase HPLC), and characterized by mass spectrometry.
Where the technology is heading
SPPS continues to evolve. Continuous-flow synthesis, an approach recognized early in the field’s history, has seen renewed interest for faster, more controlled assembly. Sustainability is another active front: because conventional SPPS relies on large volumes of hazardous solvents, researchers have explored water-compatible protecting groups such as the disulfonated Smoc group and aqueous, waste-recycling Fmoc/tBu protocols using greener solvent systems. These directions aim to keep the reliability of Merrifield’s original concept while reducing its environmental footprint.
References
- Marshall GR. Solid-phase synthesis: a paradigm shift. J Pept Sci. 2003. https://doi.org/10.1002/psc.478
- Behrendt R, White P, Offer J. Advances in Fmoc solid-phase peptide synthesis. J Pept Sci. 2016. https://doi.org/10.1002/psc.2836
- Hansen PR, Oddo A. Fmoc Solid-Phase Peptide Synthesis. Methods Mol Biol. 2015. https://doi.org/10.1007/978-1-4939-2999-3_5
- Góngora-Benítez M, Tulla-Puche J, Albericio F. Handles for Fmoc solid-phase synthesis of protected peptides. ACS Comb Sci. 2013. https://doi.org/10.1021/co300153c
- Noki S, de la Torre BG, Albericio F. Safety-Catch Linkers for Solid-Phase Peptide Synthesis. Molecules. 2024. https://doi.org/10.3390/molecules29071429
- Itoh H, Inoue M. Full solid-phase total synthesis of macrocyclic natural peptides using four-dimensionally orthogonal protective groups. Org Biomol Chem. 2019. https://doi.org/10.1039/c9ob01130g
- Gordon CP. The renascence of continuous-flow peptide synthesis. Org Biomol Chem. 2018. https://doi.org/10.1039/c7ob02759a
- Knauer S, Koch N, Uth C, et al. Sustainable Peptide Synthesis Enabled by a Transient Protecting Group. Angew Chem Int Ed Engl. 2020. https://doi.org/10.1002/anie.202003676
- Pawlas J, Rasmussen JH. Circular Aqueous Fmoc/t-Bu Solid-Phase Peptide Synthesis. ChemSusChem. 2021. https://doi.org/10.1002/cssc.202101028
Citations were retrieved from PubMed. This article is provided strictly for educational and informational purposes. All compounds referenced are research chemicals intended for laboratory and scientific research use only (RUO). They are not drugs, dietary supplements, or medical products, and are not intended for human or animal consumption, diagnosis, treatment, or any therapeutic use. Nothing here is medical advice or a recommendation for use.